# FDA Inspection 1230098 - Azenta US Inc - January 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/azenta-us-inc/55a1f881-2016-451d-917f-95ee0ab3f3e3
Source feed: FDA_Inspections

> FDA Inspection 1230098 for Azenta US Inc on January 29, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230098
- Company Name: Azenta US Inc
- Inspection Date: 2024-01-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1283224 - 2025-09-16](https://www.keypedia.com/records/fda_inspections/azenta-us-inc/36d8a907-f4bd-43c1-b7fb-969e04444f71)

Company: https://www.keypedia.com/companies/azenta-us-inc/ee5ebde6-e4a5-4263-aa59-a2cbc7de570d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d